MAT1A and metabolic dysfunction-associated steatotic liver disease: 3.2. Human NASH Can Be Classified into Metabolic and Immune NASH; MCD+HFD, GNMT-KO, MAT1A-KO, and HFCD Can Be Classified into Inflammatory, SAM Accumulation, Cholesterol/Mevalonate, and LXR/RXR-Fatty Acid β-Oxidation NAFLD, Respectively